Steven Cohen Novartis Ag Call Options Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $3.26 Million - $3.71 Million	30,700 New	30,700 $3.53 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $40 Million - $44.4 Million	-421,900 Reduced 95.8%	18,500 $1.88 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $39 Million - $44.3 Million	421,900 Added 2280.54%	440,400 $44.4 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $1.48 Million - $1.72 Million	18,500 New	18,500 $1.7 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.